Desoxycorticosterone acetate
 | |
| Clinical data | |
|---|---|
| Trade names | Percorten Acetate, Decosterone, others |
| Other names | DOCA; 11-Deoxycorticosterone 21-acetate; 21-Acetoxypregn-4-ene-3,20-dione |
| Routes of administration | Intramuscular injection |
| Drug class | Corticosteroid; Mineralocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.251 |
| Chemical and physical data | |
| Formula | C23H32O4 |
| Molar mass | 372.505 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Desoxycorticosterone acetate (also known as DOCA and 11-deoxycorticosterone 21-acetate and sold under the brand names Percorten Acetate and Decosterone, among others) is a mineralocorticoid medication and a mineralocorticoid ester.[1][2] It is formulated as an oil solution and is administered once daily by intramuscular injection.[3] The medication is the C21 acetate ester of 11-deoxycorticosterone.[1][2]
References
[edit]- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 665–. ISBN 978-1-4757-2085-3.
- 1 2 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory. Taylor & Francis. pp. 306–307. ISBN 978-3-88763-075-1.
- ↑ Chien YW (1981). "Long-acting parenteral drug formulations". J Parenter Sci Technol. 35 (3): 106–39. PMID 6113276.